1. Home
  2. ONEW vs ALXO Comparison

ONEW vs ALXO Comparison

Compare ONEW & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

N/A

Current Price

$9.23

Market Cap

157.3M

ML Signal

N/A

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

N/A

Current Price

$1.03

Market Cap

172.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONEW
ALXO
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.3M
172.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
ONEW
ALXO
Price
$9.23
$1.03
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
★ $13.00
$4.60
AVG Volume (30 Days)
101.1K
★ 1.3M
Earning Date
11-17-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.36
EPS
★ 2.77
N/A
Revenue
★ $1,872,334,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.86
N/A
P/E Ratio
$3.55
★ N/A
Revenue Growth
★ 5.62
N/A
52 Week Low
$8.12
$0.86
52 Week High
$15.25
$2.66

Technical Indicators

Market Signals
Indicator
ONEW
ALXO
Relative Strength Index (RSI) 44.63 39.08
Support Level $8.83 $0.86
Resistance Level $10.12 $1.34
Average True Range (ATR) 0.74 0.15
MACD 0.00 -0.01
Stochastic Oscillator 18.97 16.31

Price Performance

Historical Comparison
ONEW
ALXO

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: